Merck & Co., Inc.
MRK
$103.75
-$0.13-0.13%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 4.75B | -5.98B | 2.82B | 3.02B | 3.25B |
| Total Depreciation and Amortization | 978.00M | 881.00M | 970.00M | 869.00M | 938.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -183.00M | 10.43B | 438.00M | 891.00M | 1.15B |
| Change in Net Operating Assets | 2.18B | -1.64B | -2.89B | -347.00M | 263.00M |
| Cash from Operations | 7.72B | 3.70B | 1.34B | 4.43B | 5.60B |
| Capital Expenditure | -902.00M | -965.00M | -1.01B | -1.15B | -1.13B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | -10.71B | -1.33B | 0.00 | -121.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 568.00M | 227.00M | -25.00M | -599.00M | 285.00M |
| Cash from Investing | -334.00M | -11.44B | -2.36B | -1.75B | -962.00M |
| Total Debt Issued | -1.94B | 7.88B | -- | -- | -- |
| Total Debt Repaid | -1.00M | -1.75B | -1.00M | -1.00M | -1.00B |
| Issuance of Common Stock | 7.00M | 82.00M | 30.00M | 265.00M | 10.00M |
| Repurchase of Common Stock | -466.00M | -338.00M | -149.00M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.86B | -1.89B | -1.85B | -1.75B | -1.75B |
| Other Financing Activities | -10.00M | -234.00M | -81.00M | -68.00M | 35.00M |
| Cash from Financing | -4.27B | 3.76B | -2.05B | -1.55B | -2.70B |
| Foreign Exchange rate Adjustments | -157.00M | -93.00M | 87.00M | 366.00M | -412.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.96B | -4.07B | -2.99B | 1.49B | 1.53B |
